Interview with Patrick Bennett (PPD) on the challenges of biomarker assay development and the development of guidelines for such assays

23 Mar 2016

Drug development Interviews LBA MS (LC–MS/MS, HRMS, IMS) Regulated bioanalysis

We sat down with Patrick Bennett (PPD) at the recent EBF 8th Open Meeting discussing the main challenges faced when developing biomarker assays. Patrick also detailed how PPD manages the increasing demand for biomarker assays and provided his opinion on how far he believes the US FDA is from a comprehensive set of guidelines and regulations for biomarker assays.